DE3333639C2 - - Google Patents
Info
- Publication number
- DE3333639C2 DE3333639C2 DE3333639A DE3333639A DE3333639C2 DE 3333639 C2 DE3333639 C2 DE 3333639C2 DE 3333639 A DE3333639 A DE 3333639A DE 3333639 A DE3333639 A DE 3333639A DE 3333639 C2 DE3333639 C2 DE 3333639C2
- Authority
- DE
- Germany
- Prior art keywords
- sio2
- weight
- finely dispersed
- oil base
- preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 103
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 51
- 238000002360 preparation method Methods 0.000 claims abstract description 50
- 235000012239 silicon dioxide Nutrition 0.000 claims description 46
- 229910052681 coesite Inorganic materials 0.000 claims description 45
- 229910052906 cristobalite Inorganic materials 0.000 claims description 45
- 229910052682 stishovite Inorganic materials 0.000 claims description 45
- 229910052905 tridymite Inorganic materials 0.000 claims description 45
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000005480 straight-chain fatty acid group Chemical group 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 abstract description 15
- 238000000034 method Methods 0.000 abstract description 2
- 210000004351 coronary vessel Anatomy 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 31
- 239000000499 gel Substances 0.000 description 22
- 239000000969 carrier Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- -1 cyclic alcohols Chemical class 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 5
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical group 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 3
- 229960000201 isosorbide dinitrate Drugs 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000009974 thixotropic effect Effects 0.000 description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000004890 Hydrophobing Agent Substances 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 150000004671 saturated fatty acids Chemical group 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000283263 Balaenoptera edeni Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 description 1
- 239000000026 Pentaerythritol tetranitrate Substances 0.000 description 1
- 229910003910 SiCl4 Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000012963 UV stabilizer Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960003827 isosorbide mononitrate Drugs 0.000 description 1
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229960004321 pentaerithrityl tetranitrate Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 125000005624 silicic acid group Chemical class 0.000 description 1
- FDNAPBUWERUEDA-UHFFFAOYSA-N silicon tetrachloride Chemical compound Cl[Si](Cl)(Cl)Cl FDNAPBUWERUEDA-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000013008 thixotropic agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 239000010913 used oil Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833333639 DE3333639A1 (de) | 1983-09-17 | 1983-09-17 | Zubereitung von nitroestern fuer die koronartherapie |
| JP59159422A JPH0645537B2 (ja) | 1983-09-17 | 1984-07-31 | ゲル組成物またはゲル含有組成物、およびその製法 |
| EP84109987A EP0137978B1 (de) | 1983-09-17 | 1984-08-22 | Zubereitung von Nitroestern für die Koronartherapie |
| AT84109987T ATE74518T1 (de) | 1983-09-17 | 1984-08-22 | Zubereitung von nitroestern fuer die koronartherapie. |
| DE8484109987T DE3485638D1 (de) | 1983-09-17 | 1984-08-22 | Zubereitung von nitroestern fuer die koronartherapie. |
| FI843615A FI83838C (fi) | 1983-09-17 | 1984-09-14 | Foerfarande foer framstaellning av ett nitroesterpreparat foer koronarterapi. |
| ES535914A ES8505541A1 (es) | 1983-09-17 | 1984-09-14 | Procedimiento para producir una preparacion de gel o preparacion que contiene gel |
| US06/650,797 US4611008A (en) | 1983-09-17 | 1984-09-14 | Preparation of nitroesters for coronary artery therapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833333639 DE3333639A1 (de) | 1983-09-17 | 1983-09-17 | Zubereitung von nitroestern fuer die koronartherapie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3333639A1 DE3333639A1 (de) | 1985-03-28 |
| DE3333639C2 true DE3333639C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1988-01-14 |
Family
ID=6209363
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19833333639 Granted DE3333639A1 (de) | 1983-09-17 | 1983-09-17 | Zubereitung von nitroestern fuer die koronartherapie |
| DE8484109987T Expired - Lifetime DE3485638D1 (de) | 1983-09-17 | 1984-08-22 | Zubereitung von nitroestern fuer die koronartherapie. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8484109987T Expired - Lifetime DE3485638D1 (de) | 1983-09-17 | 1984-08-22 | Zubereitung von nitroestern fuer die koronartherapie. |
Country Status (7)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63222113A (ja) * | 1987-03-11 | 1988-09-16 | Kao Corp | 貼付剤組成物 |
| IE62871B1 (en) * | 1988-03-08 | 1995-03-08 | Warner Lambert Co | Compositions with enhanced penetration |
| US5019395A (en) * | 1988-03-08 | 1991-05-28 | Warner-Lambert Company | Compositions with enhanced penetration |
| US4980175A (en) * | 1989-01-03 | 1990-12-25 | Leonard Chavkin | Liquid orally administrable compositions based on edible oils |
| US4988679A (en) * | 1989-01-03 | 1991-01-29 | Leonard Chavkin | Liquid sustained release composition |
| US5122384A (en) * | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| JPH0827003A (ja) * | 1994-07-22 | 1996-01-30 | Sekisui Chem Co Ltd | 経皮吸収製剤 |
| US6787342B2 (en) * | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
| TWI307634B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 2001-03-30 | 2009-03-21 | Shiseido Co Ltd | |
| MXPA04002220A (es) * | 2001-09-10 | 2004-06-07 | Hoffmann La Roche | Formulaciones tixotropicas oleosas. |
| US20040029959A1 (en) * | 2002-08-08 | 2004-02-12 | John Devane | Isosorbide mononitrate compositions and methods of their use |
| US7109247B2 (en) | 2003-05-30 | 2006-09-19 | 3M Innovative Properties Company | Stabilized particle dispersions containing nanoparticles |
| US7459146B2 (en) * | 2003-05-30 | 2008-12-02 | 3M Innovative Properties Company | Stabilized aerosol dispersions |
| US20040242729A1 (en) * | 2003-05-30 | 2004-12-02 | 3M Innovative Properties Company | Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
| DE102005061965A1 (de) * | 2005-12-23 | 2007-07-05 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Oxidische Agglomeratpartikel, Verfahren zur Herstellung von Nanokompositen sowie deren Verwendung |
| AU2012242887B2 (en) * | 2011-04-13 | 2015-05-07 | Elc Management Llc | Conditioning agents for personal care compositions |
| KR101584878B1 (ko) | 2011-04-13 | 2016-01-13 | 이엘씨 매니지먼트 엘엘씨 | 개인 관리 조성물에 적합한 순한 음이온성 계면활성제 |
| EP2741735A1 (en) | 2011-08-12 | 2014-06-18 | Boehringer Ingelheim Vetmedica GmbH | Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
| CA2902911C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3028307A (en) * | 1959-05-27 | 1962-04-03 | Warner Lambert Pharmaceutical | Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents |
| NL110701C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1960-03-14 | |||
| US3096242A (en) * | 1960-05-20 | 1963-07-02 | Atlas Chem Ind | Vasodilator drug mixtures and excipient therefor |
| DE1642998B2 (de) * | 1967-03-23 | 1973-05-17 | Verfahren zur verhinderung der agglomeration feinteiliger, 1ulverfoermiger stoffe | |
| GB1315197A (en) * | 1970-07-13 | 1973-04-26 | Explosives & Chem Prod | Explosive gel compositions |
| US4112115A (en) * | 1976-11-08 | 1978-09-05 | Coghlan Charles C | Therapy of leg muscle cramps |
| CA1163561A (en) * | 1979-11-06 | 1984-03-13 | Cyril Boroda | Preparation containing nitroglycerine and optionally other medicaments and preparation thereof |
| AU1873783A (en) * | 1982-10-08 | 1984-04-12 | Verex Laboratories Inc. | Constant release formulation |
-
1983
- 1983-09-17 DE DE19833333639 patent/DE3333639A1/de active Granted
-
1984
- 1984-07-31 JP JP59159422A patent/JPH0645537B2/ja not_active Expired - Lifetime
- 1984-08-22 DE DE8484109987T patent/DE3485638D1/de not_active Expired - Lifetime
- 1984-08-22 AT AT84109987T patent/ATE74518T1/de not_active IP Right Cessation
- 1984-08-22 EP EP84109987A patent/EP0137978B1/de not_active Expired - Lifetime
- 1984-09-14 ES ES535914A patent/ES8505541A1/es not_active Expired
- 1984-09-14 US US06/650,797 patent/US4611008A/en not_active Expired - Lifetime
- 1984-09-14 FI FI843615A patent/FI83838C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI83838B (fi) | 1991-05-31 |
| US4611008A (en) | 1986-09-09 |
| ES535914A0 (es) | 1985-06-01 |
| EP0137978B1 (de) | 1992-04-08 |
| EP0137978A2 (de) | 1985-04-24 |
| EP0137978A3 (en) | 1986-10-08 |
| JPS6067416A (ja) | 1985-04-17 |
| JPH0645537B2 (ja) | 1994-06-15 |
| FI83838C (fi) | 1991-09-10 |
| ATE74518T1 (de) | 1992-04-15 |
| FI843615L (fi) | 1985-03-18 |
| ES8505541A1 (es) | 1985-06-01 |
| DE3333639A1 (de) | 1985-03-28 |
| DE3485638D1 (de) | 1992-05-14 |
| FI843615A0 (fi) | 1984-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3333639C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE69427589T2 (de) | Neue zusammensetzung | |
| DE3629386C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2924005C2 (de) | Isosorbiddinitrat enthaltendes Mittel | |
| EP0085882A2 (de) | Antimykotische Tampons mit hoher Wirkstoff-Freisetzung | |
| DE1934334B2 (de) | Wasserfreies Präparat auf Basis gesättigter Fettalkohole und Glykollösungsmittel | |
| DE1130556B (de) | Verfahren zur Herstellung von Antimalariapraeparaten | |
| DE3620674A1 (de) | Salbe zur behandlung von hauterkrankungen | |
| DE1467907B2 (de) | Verfahren zur herstellung von weichgelatinekapseln | |
| EP0461505B1 (de) | Nitroglycerin-Spray | |
| WO2000040236A1 (de) | Taxane enthaltende stabile und sterile emulsion und verfahren zu ihrer herstellung | |
| EP0339382B1 (de) | Verfahren zur Desodorierung von Fettsäureestergemiscchen | |
| DE3402877C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE68906513T2 (de) | Topisch anzuwendende diclofenac enthaltende arzneizubereitungen. | |
| DE4003783C2 (de) | Phospholipidhaltiges Gel, Verfahren zu dessen Herstellung und Verwendung | |
| DE4111939C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE68926162T2 (de) | Glycerophospholipidzubereitung mit erhöhter Netzmittelwirkung | |
| DE3042975A1 (de) | Mikrodispersion mit einem wirkstoff und/oder einem reagens in salzform als disperser phase | |
| DE4303818C1 (de) | Arzneimittel mit einem Gehalt an Dexpanthenol zur topischen Anwendung | |
| DE2847975A1 (de) | Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen | |
| DE2138586C2 (de) | Injektionspräparat mit Vitamin A-Wirksamkeit | |
| DE2654743A1 (de) | Therapeutikum zur externen behandlung von schuppenflechte (psoriasis), flechten und ekzemen | |
| DE4410637C1 (de) | Injizierbare Lösungen von Dirithromycin | |
| DE3047854A1 (de) | Topische salbe | |
| WO2000016770A1 (de) | Taxane enthaltende pharmazeutische zubereitung und verfahren zu ihrer herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8380 | Miscellaneous part iii |
Free format text: ES ERFOLGT NEUDRUCK DER FEHLERHAFT GEDRUCKTEN PATENTSCHRIFT |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: DYNAMIT NOBEL AG, 5210 TROISDORF, DE |
|
| 8339 | Ceased/non-payment of the annual fee |